MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Начало・Списък с акции・iRhythm Technologies Inc

iRhythm Technologies Inc

Затворен

СекторЗдравеопазване

116.66 -1.23

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

113.01

Максимум

118.91

Ключови измерители
By Trading Economics
Приходи	11M 5.6M
Продажби	16M 209M
Марж на печалбата	2.671
Служители	2,400
EBITDA	14M 16M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+78.32% upside

Дивиденти
By Dow Jones
Следващи печалби	30.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-955M 3.7B
Предишно отваряне	117.89
Предишно затваряне	116.66

Настроения в новините

By Acuity

25%

75%

72 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

104.78 / 137.91 Подкрепа & съпротива

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.04.2026 г., 22:56 ч. UTC

Значими събития в новините

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1.04.2026 г., 20:50 ч. UTC

Придобивния, сливания и поглъщания

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1.04.2026 г., 23:55 ч. UTC

Пазарно говорене

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1.04.2026 г., 23:23 ч. UTC

Значими събития в новините

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1.04.2026 г., 23:07 ч. UTC

Печалби

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1.04.2026 г., 23:02 ч. UTC

Значими събития в новините

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1.04.2026 г., 23:00 ч. UTC

Значими събития в новините

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1.04.2026 г., 23:00 ч. UTC

Значими събития в новините

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1.04.2026 г., 23:00 ч. UTC

Значими събития в новините

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1.04.2026 г., 22:39 ч. UTC

Печалби

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1.04.2026 г., 22:08 ч. UTC

Пазарно говорене

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1.04.2026 г., 22:00 ч. UTC

Значими събития в новините

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1.04.2026 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1.04.2026 г., 21:31 ч. UTC

Значими събития в новините

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

1.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

1.04.2026 г., 20:38 ч. UTC

Печалби

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1.04.2026 г., 20:31 ч. UTC

Придобивния, сливания и поглъщания

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1.04.2026 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1.04.2026 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1.04.2026 г., 20:13 ч. UTC

Придобивния, сливания и поглъщания

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1.04.2026 г., 20:07 ч. UTC

Пазарно говорене

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1.04.2026 г., 20:07 ч. UTC

Придобивния, сливания и поглъщания

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

78.32% нагоре

12-месечна прогноза

Среден 210.45 USD 78.32%

Висок 254 USD

Нисък 184 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на iRhythm Technologies Inc през последните 3 месеца.

Техническа оценка

By Trading Central

104.78 / 137.91Подкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Настроение

By Acuity

72 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.